Carmot Therapeutics Inc. (CRMO)

Carmot Therapeutics was planning to go public, but the IPO was withdrawn on Dec 11, 2023.

Stock Price: Pending

IPO price not available yet

Carmot Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Income	-67.18	-43.43	-24.59
Net Income	-51.69	-38.83	25.37

Fiscal Year	Current	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	138.34	138.34	48.03
Total Debt	4.06	4.06	30.06
Net Cash (Debt)	134.29	134.29	17.97
Net Cash Growth	-	647.36%	-

Fiscal Year	TTM	FY 2022	FY 2021
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-55.73	-37.91	-23.56
Capital Expenditures	-1.74	-1.54	-1.1
Free Cash Flow	-57.47	-39.45	-24.66
Free Cash Flow Growth	-	-	-